We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Submit a Manuscript to the Journal
Human Vaccines & Immunotherapeutics

For a Special Issue on
Initiation of the HPV vaccine series before age 11: what have we learned?

Manuscript deadline
01 August 2022

Cover image - Human Vaccines & Immunotherapeutics

Special Issue Editor(s)

Rebecca B. Perkins, Boston University School of Medicine
[email protected]

Sharon Humiston, Children's Mercy
[email protected]

Kristin Oliver, Icahn School of Medicine at Mount Sinai
[email protected]

Submit an ArticleVisit JournalArticles

Initiation of the HPV vaccine series before age 11: what have we learned?

HPV vaccination in the United States is recommended routinely at ages 11-12, but the series can begin at age 9. This issue explores evidence on whether initiation of the HPV vaccine series prior to age 11 provides benefits in terms of population coverage and/or timely completion of the series. We are soliciting papers that:

  • Compare vaccination coverage and/or completion rates by age at vaccination
  • Describe implementation or quality improvement initiatives that involve lowering the age at which vaccination is routinely recommended
  • Parent or healthcare provider experiences with HPV vaccine series initiation before age 11

Submission Instructions

  • Select "Initiation of the HPV vaccine series before age 11: what have we learned?" when submitting your paper to ScholarOne
  • Original research papers, scoping and systematic reviews, and brief reports will be considered for publication
  • Papers will be published online as they are accepted; the entire issue is expected to be published in January 2023 (in conjunction with Cervical Cancer Awareness Month)

Instructions for AuthorsSubmit an Article

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.